Literature DB >> 1326895

Revision in classification by International Federation of Gynecology and Obstetrics.

W T Creasman.   

Abstract

Mesh：

Year:  1992        PMID： 1326895     DOI： 10.1016/s0002-9378(11)91607-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  5 in total

1.  Prognostic factors in stages II/III/IV and stages III/IV endometrioid and serous adenocarcinoma of the endometrium.

Authors:  P Mhawech-Fauceglia; R F Herrmann; J Kesterson; I Izevbaye; S Lele; K Odunsi
Journal:  Eur J Surg Oncol       Date:  2010-12       Impact factor: 4.424

2.  Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma.

Authors:  Paulette Mhawech-Fauceglia; Dan Wang; Susanna Syriac; Heidi Godoy; Nefertiti Dupont; Song Liu; Kunle Odunsi
Journal:  Gynecol Oncol       Date:  2011-10-19       Impact factor: 5.482

3.  Expression and clinical significance of the transforming growth factor-β signalling pathway in endometrial cancer.

Authors:  Joshua Kesterson; Dan Wang; Paulette Mhawech-Fauceglia; Stacey Akers; Nefertiti Chianti DuPont; Kimberly Clark; Shashikant Lele; Song Liu
Journal:  Histopathology       Date:  2011-07       Impact factor: 5.087

4.  Placental site trophoblastic tumor with multiple metastases and complete response to salvage BEP regimen: a case report and review of the literature.

Authors:  Selcuk Ayas; Ayse Gurbuz; Ates Karateke; Handan Cetiner
Journal:  Med Oncol       Date:  2008-05-28       Impact factor: 3.064

5.  Claudin7 and moesin in endometrial Adenocarcinoma; a retrospective study of 265 patients.

Authors:  Paulette Mhawech-Fauceglia; Dan Wang; Shashikant Lele; Peter J Frederick; Tanja Pejovic; Song Liu
Journal:  BMC Res Notes       Date:  2012-01-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.